Latin American Regulators Aligning API Registration Requirements with CTD
This article was originally published in The Gold Sheet
Executive Summary
Regulators in Latin America are requiring more information on drug substance manufacture and are incorporating the International Conference on Harmonization’s Common Technical Document in their registration requirements as the basis for this information.
You may also be interested in...
Global Harmonization of CMC Review Explored
Quality by design (QbD) and certificates of pharmaceutical product (CPPs) suggested as concepts the world’s regulatory authorities could use to harmonize CMC requirements so new medicines could reach their markets more quickly. Meanwhile, in the world’s regulatory affairs trenches, industry is engaged in a complex, difficult, country by country, region by region lobbying effort.
Stability Testing Requirements Proliferate Globally While Manufacturers Develop Better, Faster Methods
Regulatory agencies in developing economies around the world are setting stability testing requirements that do not mirror domestic climatic conditions, creating an obstacle for manufacturers that want to submit stability data globally.
Program Participants Urge The FDA To Adopt Some Pharmaceutical Quality Metrics And Avoid Others
Site-based metrics praised; lot acceptance rates, invalidated OOS rates discouraged. Agency official admits some proposed metrics were “not the best.”